Ribonucleic Acid News and Research

RSS

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

In a new study, researchers discovered human monoclonal antibodies, which were specific and potent against the severe acute respiratory syndrome coronavirus 2 Omicron variant.

23 Mar 2022

Natural infection versus messenger RNA vaccination-induced immune protection

Researchers compared the immune protection provided by naturally acquired COVID-19 and its vaccination in Qatar residents.

23 Mar 2022

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Researchers reported a new monoclonal antibody, P2G3, which significantly neutralized the SARS-CoV-2 Omicron variant.

23 Mar 2022

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

In a new study, researchers explored the germinal center of antibody-mediated immunity towards SARS-CoV-2.

23 Mar 2022

Newly emerged-hygiene issue in the current lifestyles of wearing face masks during the COVID-19 pandemic

A recent article evaluated a novel hygiene concern that emerged during the COVID-19 pandemic, i.e., the adherence of fungi and bacteria to face masks.

23 Mar 2022

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Monitoring SARS-CoV-2 Ct values during early infection

A new study tracks the fluctuations in viral load in people recently infected with SARS-CoV-2.

22 Mar 2022

COVID booster vaccination more effective relative to 2-dose series

A booster dose of a mRNA-based COVID-19 vaccine is more effective than the two-dose primary vaccination regimen in preventing SARS-CoV-2 infections.

22 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

A new study investigated the interactions between SARS-CoV-2 proteins and viral and host ribonucleic acid in virus-infected cells.

22 Mar 2022

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Researchers evaluated the importance of the Ex3Lx6L motif in SARS-CoV-2 entry into host cells mediated by the spike protein syncytium formation and membrane fusion.

22 Mar 2022

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

A recent study posted to the bioRxiv* preprint server demonstrated the neutralizing capacity of existing SARS-CoV-2 vaccines against the severe acute respiratory coronavirus 2 (SARS-CoV-2) Omicron BA.2 and BA.1 sublineages.

22 Mar 2022

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

In a recent study posted to the bioRxiv* preprint server, researchers conducted a phylogenetic investigation of the human parainfluenza type 3 virus strain (HPIV3) that caused an outbreak in South Korea amid the coronavirus disease 2019 (COVID-19) pandemic.

22 Mar 2022

Ribonucleic Acid News and Research

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Natural infection versus messenger RNA vaccination-induced immune protection

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

Newly emerged-hygiene issue in the current lifestyles of wearing face masks during the COVID-19 pandemic

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Monitoring SARS-CoV-2 Ct values during early infection

COVID booster vaccination more effective relative to 2-dose series

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

Is COVID-19 on the verge of ending?

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Could COVID-19 spread through wastewater in the Thames?

Using CRISPR/Cas to develop biosafety materials

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Study evaluates colorimetric sensors for SARS-CoV-2 detection using gold nanoparticles

Neutralizing antibody responses against parental SARS-CoV-2 strain as well as against Omicron BA.1 and BA.2 variants

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News